These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35168081)

  • 1. Efficacy of high-dose intravenous immunoglobulin in severe and critical COVID-19: A retrospective cohort study.
    Aggarwal R; Dewan A; Pandey A; Trehan N; Majid MA
    Int Immunopharmacol; 2022 May; 106():108615. PubMed ID: 35168081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The outcome of using intravenous immunoglobulin (IVIG) in critically ill COVID-19 patients': a retrospective, multi-centric cohort study.
    Salehi M; Barkhori Mehni M; Akbarian M; Fattah Ghazi S; Khajavi Rad N; Moradi Moghaddam O; Jamali Moghaddam S; Hosseinzadeh Emam M; Abtahi SH; Moradi M; Ghiasvand F
    Eur J Med Res; 2022 Feb; 27(1):18. PubMed ID: 35115056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Intravenous Immunoglobulin (Prevagen or Octagam) for the Treatment of COVID-19: Retrospective Case Series.
    Herth FJF; Sakoulas G; Haddad F
    Respiration; 2020; 99(12):1145-1153. PubMed ID: 33316806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early combination therapy with immunoglobulin and steroids is associated with shorter ICU length of stay in Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19: A retrospective cohort analysis from 28 U.S. Hospitals.
    Harthan AA; Nadiger M; McGarvey JS; Hanson K; Gharpure VP; Bjornstad EC; Chiotos K; Miller AS; Reikoff RA; Gajic O; Kumar V; Walkey AJ; Kashyap R; Tripathi S;
    Pharmacotherapy; 2022 Jul; 42(7):529-539. PubMed ID: 35661394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes of intravenous immunoglobulin therapy in COVID-19 related acute respiratory distress syndrome: a retrospective cohort study.
    Ali HS; Elshafei MS; Saad MO; Mitwally HA; Al Wraidat M; Aroos A; Shaikh N; Ananthegowda DC; Abdelaty MA; George S; Nashwan AJ; Mohamed AS; Khatib MY
    BMC Pulm Med; 2021 Nov; 21(1):354. PubMed ID: 34743710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulin-based adjuvant therapy for severe COVID-19: a single-center retrospective cohort study.
    Hou X; Tian L; Zhou L; Jia X; Kong L; Xue Y; Hao H; Meng X; Zhang F; Dong X
    Virol J; 2021 May; 18(1):101. PubMed ID: 34020680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of early treatment with polyvalent immunoglobulin on acute respiratory distress syndrome associated with SARS-CoV-2 infections (ICAR trial): study protocol for a randomized controlled trial.
    Mazeraud A; Gonçalves B; Aegerter P; Mancusi L; Rieu C; Bozza F; Sylla K; Siami S; Sharshar T
    Trials; 2021 Feb; 22(1):170. PubMed ID: 33648563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial.
    Tabarsi P; Barati S; Jamaati H; Haseli S; Marjani M; Moniri A; Abtahian Z; Dastan A; Yousefian S; Eskandari R; Saffaei A; Monjazebi F; Vahedi A; Dastan F
    Int Immunopharmacol; 2021 Jan; 90():107205. PubMed ID: 33214093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy evaluation of intravenous immunoglobulin in non-severe patients with COVID-19: A retrospective cohort study based on propensity score matching.
    Huang C; Fei L; Li W; Xu W; Xie X; Li Q; Chen L
    Int J Infect Dis; 2021 Apr; 105():525-531. PubMed ID: 33434674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of intravenous immunoglobulins on the outcomes of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials.
    Lai CC; Chen WC; Chen CY; Wei YF
    Expert Rev Anti Infect Ther; 2022 Oct; 20(10):1333-1340. PubMed ID: 35786174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of adjunct treatment with intravenous immunoglobulins on the course of severe COVID-19: results from a retrospective cohort study.
    Esen F; Özcan PE; Orhun G; Polat Ö; Anaklı İ; Alay G; Tuna V; Çeliksoy E; Kılıç M; Mercan M; Tukek T
    Curr Med Res Opin; 2021 Apr; 37(4):543-548. PubMed ID: 33236646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperimmune anti-COVID-19 IVIG (C-IVIG) Therapy for Passive Immunization of Severe and Critically Ill COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial.
    Ali S; Luxmi S; Anjum F; Muhaymin SM; Uddin SM; Ali A; Ali MR; Tauheed S; Khan M; Bajwa M; Baig SU; Shalim E; Ahmed I; Khan AS; Quraishy S
    Trials; 2020 Nov; 21(1):905. PubMed ID: 33138867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immunoglobulin as an important adjunct in the prevention and therapy of coronavirus 2019 disease.
    Danieli MG; Piga MA; Paladini A; Longhi E; Mezzanotte C; Moroncini G; Shoenfeld Y
    Scand J Immunol; 2021 Nov; 94(5):e13101. PubMed ID: 34940980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
    Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
    Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
    Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
    Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intravenous immunoglobulin on the outcome of children with septic shock in a PICU: a retrospective cohort study.
    Huang H; Chen J; Dang H; Liu C; Huo J; Fu YQ
    Eur J Pediatr; 2023 Dec; 182(12):5315-5323. PubMed ID: 37733114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immunoglobulin treatment for patients with severe COVID-19: a retrospective multicentre study.
    Liu J; Chen Y; Li R; Wu Z; Xu Q; Li Z; Annane D; Feng H; Huang S; Guo J; Zhang L; Ye X; Zhu W; Du H; Liu Y; Wang T; Chen L; Wen Z; Teboul JL; Chen D
    Clin Microbiol Infect; 2021 Oct; 27(10):1488-1493. PubMed ID: 34020032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
    Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
    Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.